Skip to main navigation Skip to search Skip to main content

2-(2-(2,4-dioxopentan-3-ylidene)hydrazineyl)benzonitrile as novel inhibitor of receptor tyrosine kinase and PI3K/AKT/mTOR signaling pathway in glioblastoma

  • Anisha Viswanathan
  • , Dinesh Kute
  • , Aliyu Musa
  • , Saravanan Konda Mani
  • , Vili Sipilä
  • , Frank Emmert-Streib
  • , Fedor I. Zubkov
  • , Atash V. Gurbanov
  • , Olli Yli-Harja
  • , Meenakshisundaram Kandhavelu*
  • *Corresponding author for this work
  • Tampere University
  • University of Madras
  • People's Friendship University of Russia
  • University of Lisbon
  • Baku State University
  • Institute for Systems Biology

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of '2-(2-(2,4-dioxopentan-3-ylidene)hydrazineyl)benzonitrile as novel inhibitor of receptor tyrosine kinase and PI3K/AKT/mTOR signaling pathway in glioblastoma'. Together they form a unique fingerprint.
Sort by

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science

Neuroscience